CNIO scientists challenge the efficacy of folfiri in a colorectal cancer subtype

They warn that an erroneous correlation between drug and ‘stemlike’ colon cancer subtype could lead oncologists to prescribe inadequate treatmentsResults are presented this week in the journal ‘Nature Medicine’. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *